Muromonab
- Generic Name
- Muromonab
- Drug Type
- Biotech
- CAS Number
- 140608-64-6
- Unique Ingredient Identifier
- JGA39ICE2V
Overview
Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a).
Background
Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a).
Indication
For treatment of organ transplant recipients, prevention of organ rejection
Associated Conditions
- Acute Renal Allograft Rejection
- Steroid resistant Heart transplant rejection
- Steroid resistant hepatic transplant rejection
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.